NO20030299L - Karbamatforbindelser for anvendelse ved prevensjon eller terapi av neuropatisk smerte og cluster- og migrenehodepineassosiert smerte - Google Patents

Karbamatforbindelser for anvendelse ved prevensjon eller terapi av neuropatisk smerte og cluster- og migrenehodepineassosiert smerte

Info

Publication number: NO20030299L
Authority: NO; Norway
Prior art keywords: pain; cluster; migraine headache; therapy; prevention
Prior art date: 2000-07-21

Application number

NO20030299A

Other languages

English (en)

Other versions

NO330055B1 (no

NO20030299D0 (no

Inventor

Ellen E Codd

Richard P Shank

Katherine E Rogers

Carlos R Plata-Salaman

Boyu Zhao

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-21

Filing date

2003-01-20

Publication date

2003-03-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22820176&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20030299(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-01-20 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2003-01-20 Publication of NO20030299D0 publication Critical patent/NO20030299D0/no

2003-03-12 Publication of NO20030299L publication Critical patent/NO20030299L/no

2011-02-14 Publication of NO330055B1 publication Critical patent/NO330055B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20030299A 2000-07-21 2003-01-20 Karbamatforbindelser til anvendelse for fremstilling av et medikament for forebygging eller terapi av neuropatisk smerte samt cluster- og migrenehodepineassosiert smerte NO330055B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US21965700P	2000-07-21	2000-07-21
PCT/US2001/022322 WO2002007822A2 (en)	2000-07-21	2001-07-16	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Publications (3)

Publication Number	Publication Date
NO20030299D0 NO20030299D0 (no)	2003-01-20
NO20030299L true NO20030299L (no)	2003-03-12
NO330055B1 NO330055B1 (no)	2011-02-14

Family

ID=22820176

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030299A NO330055B1 (no)	2000-07-21	2003-01-20	Karbamatforbindelser til anvendelse for fremstilling av et medikament for forebygging eller terapi av neuropatisk smerte samt cluster- og migrenehodepineassosiert smerte

Country Status (28)

Country	Link
US (4)	US20020107283A1 (no)
EP (1)	EP1305082B1 (no)
JP (1)	JP5271473B2 (no)
KR (1)	KR100792814B1 (no)
CN (1)	CN1250213C (no)
AT (1)	ATE267629T1 (no)
AU (2)	AU7349301A (no)
BG (1)	BG107529A (no)
BR (1)	BR0112713A (no)
CA (1)	CA2416819C (no)
CZ (1)	CZ2003445A3 (no)
DE (1)	DE60103546T2 (no)
DK (1)	DK1305082T3 (no)
EA (1)	EA005648B1 (no)
ES (1)	ES2221651T3 (no)
HU (1)	HUP0302940A3 (no)
IL (2)	IL154052A0 (no)
MX (1)	MXPA03000619A (no)
MY (1)	MY127317A (no)
NO (1)	NO330055B1 (no)
NZ (1)	NZ523851A (no)
PL (1)	PL365701A1 (no)
PT (1)	PT1305082E (no)
SK (1)	SK1962003A3 (no)
TR (1)	TR200401511T4 (no)
UA (1)	UA74195C2 (no)
WO (1)	WO2002007822A2 (no)
ZA (1)	ZA200301403B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP0303236A3 (en) *	2001-02-27	2012-07-30	Ortho Mcneil Pharm Inc	Carbamate compounds for use in the treatment of pain
HUP0401110A3 (en) *	2001-07-16	2012-09-28	Ortho Mcneil Pharm Inc	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
CN1259911C (zh)	2001-07-16	2006-06-21	奥索-麦克尼尔药品公司	用于预防或治疗神经性疼痛和丛集性头痛及偏头痛性疼痛的氨基甲酸酯化合物
US20040087642A1 (en) *	2002-10-24	2004-05-06	Zeldis Jerome B.	Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain
US7323443B2 (en) *	2002-12-12	2008-01-29	Agennix Inc.	Lactoferrin in the reduction of pain
US7183381B2 (en) *	2004-10-26	2007-02-27	Agennix, Inc.	Composition of lactoferrin related peptides and uses thereof
CA2595599A1 (en) *	2005-01-20	2006-07-27	Janssen Pharmaceutica N.V.	Methods for qt interval control
EA015833B1 (ru)	2006-03-30	2011-12-30	Глаксосмитклайн Байолоджикалс С.А.	Иммуногенная композиция
WO2008063284A2 (en) *	2006-10-10	2008-05-29	Janssen Pharmaceutica Nv	Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US20150057351A1 (en) *	2013-08-22	2015-02-26	Sucampo Ag	Method for treating neuropathic pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3278380A (en) *	1962-02-06	1966-10-11	Armour Pharma	Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) *	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
HU191549B (en) *	1984-04-11	1987-03-30	Richter Gedeon Vegyeszet	Process for producing 1-/6-/2 comma above-substituted-5 comma above, 6 comma above, 7 comma above, 8 comma above-tetrahydro-4 comma above-oxo-quinazolino//-3,4-dihydro-6,7-disubstituted-isoquinoline derivatives
US4868190A (en) *	1988-12-27	1989-09-19	Hoechst-Roussel Pharmaceuticals, Inc.	N-pyridinyl-9H-carbazol-9-amines
GB9518027D0 (en) *	1995-09-05	1995-11-08	Wellcome Found	Pharmacologically active compound
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
EE9900560A (et) *	1997-06-05	2000-06-15	Sanofi-Synthlabo	5-naftaleen-1-üül-1,3-dioksaani derivaadid, nende valmistamine ja terapeutiline kasutamine
CA2439478C (en) *	2001-02-27	2010-05-18	Carlos R. Plata-Salaman	Carbamate compounds for use in preventing or treating movement disorders
DE60210976T2 (de) *	2001-02-27	2007-05-24	Ortho-Mcneil Pharmaceutical, Inc.	Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung
EP1401424B1 (en) *	2001-02-27	2006-11-29	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating psychotic disorders

2001
- 2001-07-16 PT PT01952773T patent/PT1305082E/pt unknown
- 2001-07-16 MX MXPA03000619A patent/MXPA03000619A/es active IP Right Grant
- 2001-07-16 DK DK01952773T patent/DK1305082T3/da active
- 2001-07-16 HU HU0302940A patent/HUP0302940A3/hu unknown
- 2001-07-16 US US09/906,251 patent/US20020107283A1/en not_active Abandoned
- 2001-07-16 CN CNB01815798XA patent/CN1250213C/zh not_active Expired - Fee Related
- 2001-07-16 CA CA2416819A patent/CA2416819C/en not_active Expired - Fee Related
- 2001-07-16 ES ES01952773T patent/ES2221651T3/es not_active Expired - Lifetime
- 2001-07-16 EP EP01952773A patent/EP1305082B1/en not_active Expired - Lifetime
- 2001-07-16 SK SK196-2003A patent/SK1962003A3/sk unknown
- 2001-07-16 EA EA200300042A patent/EA005648B1/ru not_active IP Right Cessation
- 2001-07-16 AU AU7349301A patent/AU7349301A/xx active Pending
- 2001-07-16 AT AT01952773T patent/ATE267629T1/de not_active IP Right Cessation
- 2001-07-16 PL PL01365701A patent/PL365701A1/xx not_active Application Discontinuation
- 2001-07-16 TR TR2004/01511T patent/TR200401511T4/xx unknown
- 2001-07-16 WO PCT/US2001/022322 patent/WO2002007822A2/en not_active Ceased
- 2001-07-16 KR KR1020037000914A patent/KR100792814B1/ko not_active Expired - Lifetime
- 2001-07-16 CZ CZ2003445A patent/CZ2003445A3/cs unknown
- 2001-07-16 JP JP2002513552A patent/JP5271473B2/ja not_active Expired - Lifetime
- 2001-07-16 BR BR0112713-6A patent/BR0112713A/pt not_active Application Discontinuation
- 2001-07-16 NZ NZ523851A patent/NZ523851A/en unknown
- 2001-07-16 UA UA2003010559A patent/UA74195C2/uk unknown
- 2001-07-16 IL IL15405201A patent/IL154052A0/xx unknown
- 2001-07-16 DE DE60103546T patent/DE60103546T2/de not_active Expired - Lifetime
- 2001-07-16 AU AU2001273493A patent/AU2001273493B2/en not_active Ceased
- 2001-07-20 MY MYPI20013443 patent/MY127317A/en unknown
2003
- 2003-01-20 IL IL154052A patent/IL154052A/en unknown
- 2003-01-20 NO NO20030299A patent/NO330055B1/no not_active IP Right Cessation
- 2003-02-05 BG BG107529A patent/BG107529A/bg unknown
- 2003-02-20 ZA ZA200301403A patent/ZA200301403B/en unknown
2004
- 2004-06-15 US US10/868,633 patent/US20040266866A1/en not_active Abandoned
2005
- 2005-02-18 US US11/194,876 patent/US20060183795A1/en not_active Abandoned
2009
- 2009-07-20 US US12/505,765 patent/US20090281179A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO330055B1 (no)	2011-02-14
CN1250213C (zh)	2006-04-12
EP1305082B1 (en)	2004-05-26
KR100792814B1 (ko)	2008-01-14
CA2416819A1 (en)	2002-01-31
AU7349301A (en)	2002-02-05
HUP0302940A2 (hu)	2003-12-29
ES2221651T3 (es)	2005-01-01
DE60103546D1 (de)	2004-07-01
ATE267629T1 (de)	2004-06-15
CZ2003445A3 (cs)	2004-08-18
PL365701A1 (en)	2005-01-10
WO2002007822A3 (en)	2002-05-30
CA2416819C (en)	2011-03-22
US20060183795A1 (en)	2006-08-17
BR0112713A (pt)	2003-07-22
US20020107283A1 (en)	2002-08-08
JP5271473B2 (ja)	2013-08-21
EP1305082A2 (en)	2003-05-02
PT1305082E (pt)	2004-09-30
DE60103546T2 (de)	2005-06-09
MXPA03000619A (es)	2004-07-30
US20040266866A1 (en)	2004-12-30
IL154052A0 (en)	2003-07-31
DK1305082T3 (da)	2004-09-13
AU2001273493B2 (en)	2005-08-11
KR20030022300A (ko)	2003-03-15
BG107529A (bg)	2003-09-30
ZA200301403B (en)	2004-06-15
HUP0302940A3 (en)	2012-02-28
MY127317A (en)	2006-11-30
IL154052A (en)	2008-07-08
US20090281179A1 (en)	2009-11-12
EA200300042A1 (ru)	2003-06-26
JP2004504362A (ja)	2004-02-12
NO20030299D0 (no)	2003-01-20
WO2002007822A2 (en)	2002-01-31
NZ523851A (en)	2004-09-24
TR200401511T4 (tr)	2004-08-23
EA005648B1 (ru)	2005-04-28
UA74195C2 (uk)	2005-11-15
SK1962003A3 (en)	2004-08-03
CN1458853A (zh)	2003-11-26

Publication	Publication Date	Title
YU68003A (sh)	2006-08-17	Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja
NO20033802D0 (no)	2003-08-26	Karbamatforbindelser for anvendelse ved forebygging eller behandling av bipolar forstyrrelse
NO20030299D0 (no)	2003-01-20	Karbamatforbindelser for anvendelse ved prevensjon eller terapi av neuropatisk smerte og cluster- og migrenehodepineassosiert smerte
DK1399144T3 (da)	2006-07-24	Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af angstforstyrrelser
NO20040176L (no)	2004-03-12	Karbamatforbindelser for anvendelse ved prevensjon eller terapi av neuropatisk smerte og kluster- og migrenehodepineassosiert smerte
PL368112A1 (en)	2005-03-21	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY137446A (en)	2009-01-30	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY136347A (en)	2008-09-30	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Legal Events

Date	Code	Title	Description
2012-02-20	MM1K	Lapsed by not paying the annual fees